<--- Back to Details
First PageDocument Content
Biology / Eli Lilly and Company / Glycopeptide antibiotics / Vancomycin / Defined daily dose / Nosocomial infection / Antibiotic resistance / Fusidic acid / Ertapenem / Medicine / Health / Antibiotics
Date: 2014-04-07 12:17:02
Biology
Eli Lilly and Company
Glycopeptide antibiotics
Vancomycin
Defined daily dose
Nosocomial infection
Antibiotic resistance
Fusidic acid
Ertapenem
Medicine
Health
Antibiotics

Antimicrobial Stewardship: Arizona Partnerships Working to Improve the Use of Antimicrobials in the Hospital and Community Part 5 “Antibacterials – indeed, anti-infectives as a whole – are unique in that misuse of

Add to Reading List

Source URL: azdhs.gov

Download Document from Source Website

File Size: 263,29 KB

Share Document on Facebook

Similar Documents

Microsoft Word - Arsanis_ASMMicrobe_Press_Release_6.17.16_FINAL_forWebsite.docx

Microsoft Word - Arsanis_ASMMicrobe_Press_Release_6.17.16_FINAL_forWebsite.docx

DocID: 1qhh2 - View Document

Microorganisms Identified in Central Line-Associated Blood Stream Infections (CLABSI) in Illinois Hospital Intensive Care Units Reporting Period: /2014 A variety of organisms are found to contribute to c

Microorganisms Identified in Central Line-Associated Blood Stream Infections (CLABSI) in Illinois Hospital Intensive Care Units Reporting Period: /2014 A variety of organisms are found to contribute to c

DocID: 1oYlM - View Document

Carbapenem Non-Susceptible Cases in Utah, 2014 In May 2013, the Utah Department of Health (UDOH) changed the Communicable Disease Rule (Rule R386-702) to include reporting of certain healthcare-associated infections (HAI

Carbapenem Non-Susceptible Cases in Utah, 2014 In May 2013, the Utah Department of Health (UDOH) changed the Communicable Disease Rule (Rule R386-702) to include reporting of certain healthcare-associated infections (HAI

DocID: 1oCN0 - View Document

MSSA Methicillin-(Oxacillin-) sensible Staphylococcus aureus MRSA Methicillin-(Oxacillin-) resistente Staphylococcus aureus 1 MRSA-Rate in Blutkulturen: 4%

MSSA Methicillin-(Oxacillin-) sensible Staphylococcus aureus MRSA Methicillin-(Oxacillin-) resistente Staphylococcus aureus 1 MRSA-Rate in Blutkulturen: 4%

DocID: 1ntEe - View Document

Epidemiological surveillance of carbapenemase producing enterobacteriacea (CPE) Lessons for the future  Béatrice Jans & Prof. Youri Glupczynski

Epidemiological surveillance of carbapenemase producing enterobacteriacea (CPE) Lessons for the future Béatrice Jans & Prof. Youri Glupczynski

DocID: 1aT6J - View Document